Bozdağ Sibel, Gümüş Koray, Gümüş Ozlem, Unlü Nurşen
Department of Pharmaceutical Technology, Hacettepe University, Sihhiye, Ankara, Turkey.
Eur J Pharm Biopharm. 2008 Sep;70(1):260-9. doi: 10.1016/j.ejpb.2008.04.010. Epub 2008 Apr 24.
In the present study, viscous solutions of cysteamine hydrochloride (CH) were prepared by using 0.5%, 1.0%, 1.5% or 3.0% of hydroxypropylmethylcellulose (HPMC) and were evaluated for their in-vitro characteristics and stability. Osmolalities, pH and viscosity of the formulations were determined. The influence of benzalkonium chloride and autoclave sterilization on solution characteristics was also investigated. For stability assessment, the viscous solutions were stored at +4 and +25 degrees C over 12 months. In-vitro characteristics and CH contents of the stored solutions were monitored. Irritation tests for the formulations were evaluated on rabbit eyes. Dialysis sac technique was used to perform in vitro release study of the solutions containing 1.0% and 1.5% HPMC. All of the viscous solutions tested showed non-newtonian (dilatant) flow behavior. Osmolality values were ranked between 351.2+/-6.2 and 355.1+/-7.9 mOsm kg(-1), and pH values were between 3.97+/-0.1 and 3.98+/-0.2 for all the solutions. Furthermore, no significant changes in dilatant behavior, osmolality or pH values of the pure HPMC solutions were observed. After addition of the excipients or CH-excipients, increased viscosity values were noted in these formulations. Neither benzalkonium chloride nor autoclave sterilization had any influence on viscosity, pH or osmolality values of the solution containing 1.5% HPMC. Stability studies showed that a faster decrease in the concentration of CH was observed in the formulations stored at 25 degrees C compared to those kept at 4 degrees C; no changes were determined in osmolality values of the solutions at all storage conditions. Increased pH and decreased viscosity values were noted in HPMC solutions containing CH and excipients, while no changes in these values were observed for pure HPMC solutions kept at 4 and 25 degrees C. In vitro release tests revealed that 81.2% and 85.3% of CH were released from the viscous solutions containing 1.5% and 1% HPMC, respectively, in 8h. No irritation was observed when the viscous solutions were tested on rabbit and human eyes.
在本研究中,使用0.5%、1.0%、1.5%或3.0%的羟丙基甲基纤维素(HPMC)制备了盐酸半胱胺(CH)的粘性溶液,并对其体外特性和稳定性进行了评估。测定了制剂的渗透压、pH值和粘度。还研究了苯扎氯铵和高压灭菌对溶液特性的影响。为了进行稳定性评估,将粘性溶液在4℃和25℃下储存12个月。监测储存溶液的体外特性和CH含量。在兔眼上对制剂进行刺激性试验。采用透析袋技术对含有1.0%和1.5%HPMC的溶液进行体外释放研究。所有测试的粘性溶液均表现出非牛顿(胀流型)流动行为。所有溶液的渗透压值在351.2±6.2至355.1±7.9 mOsm kg(-1)之间,pH值在3.97±0.1至3.98±0.2之间。此外,未观察到纯HPMC溶液的胀流行为、渗透压或pH值有显著变化。加入辅料或CH-辅料后,这些制剂的粘度值增加。苯扎氯铵和高压灭菌对含有1.5%HPMC的溶液的粘度、pH值或渗透压值均无影响。稳定性研究表明,与在4℃保存的制剂相比,在25℃保存的制剂中观察到CH浓度下降更快;在所有储存条件下,溶液的渗透压值均未发生变化。在含有CH和辅料的HPMC溶液中观察到pH值升高和粘度值降低,而在4℃和25℃保存的纯HPMC溶液中未观察到这些值的变化。体外释放试验表明,在8小时内,分别有81.2%和85.3%的CH从含有1.5%和1%HPMC的粘性溶液中释放出来。当在兔眼和人眼上测试粘性溶液时,未观察到刺激性。